HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mei-Yee Kiang Selected Research

efipladib

10/2015Targeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mei-Yee Kiang Research Topics

Disease

1Neoplasms (Cancer)
10/2015
1Prostatic Neoplasms (Prostate Cancer)
10/2015

Drug/Important Bio-Agent (IBA)

1efipladibIBA
10/2015
1EnzymesIBA
10/2015
1LysophospholipidsIBA
10/2015
1Phospholipases (Phospholipase)IBA
10/2015
1Arachidonic Acid (Vitamin F)IBA
10/2015
1Glycerophospholipids (Phosphoglycerides)IBA
10/2015